Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Zhiyuan Li

Yuxian People's Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Rezvilutamide combined with ADT in an HIV-positive patient with high-volume mHSPC on efavirenz-based antiretroviral therapy: a case report

Frontiers in Oncology

A single case report with no comparator, describing anecdotal response to a novel drug combination in an unusual population; insufficient to change practice or confirm efficacy.

PreliminaryProstate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Yujie Gao

Reported

PSA baseline21,788.320 ng/mL

PSA nadir4.315 ng/mL

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support